These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1136858)

  • 1. Polymorphic acetylation of procaine amide in healthy subjects.
    Karlsson E; Molin L
    Acta Med Scand; 1975 Apr; 197(4):299-302. PubMed ID: 1136858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype.
    Gibson TP; Matusik J; Matusik E; Nelson HA; Wilkinson J; Briggs WA
    Clin Pharmacol Ther; 1975 Apr; 17(4):395-9. PubMed ID: 1122681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic acetylation procainamide in man.
    Reidenberg MM; Drayer DE; Levy M; Warner H
    Clin Pharmacol Ther; 1975 Jun; 17(6):722-30. PubMed ID: 237647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases.
    Molin L; Larsson R; Karlsson E
    Acta Med Scand; 1977; 201(3):217-22. PubMed ID: 848360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.
    Sonnhag C; Karlsson E; Hed J
    Acta Med Scand; 1979; 206(4):245-51. PubMed ID: 92167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway.
    Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH
    Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine acetylation may be effected by acetyltransferases other than NAT1 or NAT2.
    Bras AP; Hoff HR; Aoki FY; Sitar DS
    Can J Physiol Pharmacol; 1998; 76(7-8):701-6. PubMed ID: 10030449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.
    Lima JJ; Conti DR; Goldfarb AL; Tilstone WJ; Golden LH; Jusko WJ
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):69-85. PubMed ID: 458558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acecainide pharmacokinetics in normal subjects of known acetylator phenotype.
    Coyle JD; Boudoulas H; Lima JJ
    Biopharm Drug Dispos; 1991 Nov; 12(8):599-612. PubMed ID: 1724922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide.
    Ylitalo P; Ruosteenoja R; Leskinen O; Metsä-Ketelä T
    Eur J Clin Pharmacol; 1983; 25(6):791-5. PubMed ID: 6198178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
    Gawrońska-Szklarz B; Górnik W; Kutrzeba J; Wójcicki J; Zakrzewski J
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):921-3. PubMed ID: 1284448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation of procaine amide in man studied with a new gas chromatographic method.
    Karlsson E; Molin L; Norlander B; Sjöqvist F
    Br J Clin Pharmacol; 1974 Dec; 1(6):467-75. PubMed ID: 22454932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical consequences of polymorphic acetylation of basic drugs.
    Drayer DE; Reidenberg MM
    Clin Pharmacol Ther; 1977 Sep; 22(3):251-8. PubMed ID: 19187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the acetylation of procainamide and sulfadimidine in man.
    Frislid K; Berg M; Hansteen V; Lunde PK
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):433-8. PubMed ID: 971707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
    Ylitalo P; Hinkka H
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.